Clinical trial
A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the…
NCT00293813 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00293813 |
|---|---|
| Title | A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density |
| Official title | A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postmenopausal Osteoporosis |
| Intervention type | Drug |
| Interventions | Alendronate, Denosumab, Placebo |
| Enrollment | 247 |
| Start date | May 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Feb 20, 2006 |
| Last update posted | Jul 25, 2014 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: